glp-1 drugs and parkinson's disease

glp-1 drugs and parkinson's disease Are we measuring the wrong primary outcome for for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep Glucagon-like peptide-1 class drugs show

Name: glp-1 drugs and parkinson's disease Are we measuring the wrong primary outcome for for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep Glucagon-like peptide-1 class drugs show
Brand: aeroscroll.com
SKU: 22840502657
Price: 28.50 USD
Availability: InStock
Rating: 4.8163 (22 reviews)

SKU: 22840502657

4.8

USD28.50 USD58.50

Pay in 4 interest-free payments of $7.12 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 22 - Aug 27

Description

Chronic diseases that affect red blood cell production, such as cancer, liver disease, chronic kidney disease, immunodeficiency, HIV infection, and rheumatoid arthritis, impair bone marrow function and result in fewer red blood cells